65
Participants
Start Date
January 4, 2023
Primary Completion Date
February 28, 2026
Study Completion Date
August 31, 2028
RGX-202
RGX-202 is a recombinant AAV8 containing a transgene encoding a novel microdystrophin
RECRUITING
Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
RECRUITING
Children's Hospital of the King's Daughters, Norfolk
RECRUITING
Rare Disease Research, Atlanta
NOT_YET_RECRUITING
Cincinnati Children's, Cincinnati
RECRUITING
University of Iowa, Iowa City
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
Arkansas Children's Hospital, Little Rock
RECRUITING
The University of Texas Southwestern Medical Center, Dallas
RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
Stanford School of Medicine /Division of Neuromuscular Medicine, Palo Alto
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
University of Massachusetts Chan Medical School, Worcester
NOT_YET_RECRUITING
Alberta Children's Hospital, Calgary
RECRUITING
BC Children's Hospital, Vancouver
RECRUITING
Children's Hospital London Health Science Centre, London
RECRUITING
Children's Hospital of Eastern Ontario, Ottawa
REGENXBIO Inc.
INDUSTRY